
Population (July 2006 estimate)
43.5m
GDP (2005 - PPP basis)
$303.7bn
Health expenditure (2004)
Health expenditure as proportion of GDP (2004)
Health spend as proportion of GDP (predicted 2007)
Size of pharmaceutical market (2004 estimate)
Percentage of GDP spent on pharmaceuticals (2004)
Pharmaceutical market growth rate
Local currency
Colombian Peso (COP)
Summary: Colombia
The Colombian government is attempting to introduce healthcare reform and is concerned over the rising price of pharmaceuticals. It has launched a nationwide investigation into product pricing to uncover and punish illegal practices. It has also introduced measures to prevent manufacturers from promoting products that do not require a prescription.
Summary of report content
- Summary
- How is the healthcare system structured?
- What size is the pharmaceutical market?
- Are pharmaceuticals taxed?
- How are drug prices set?
- How are prices changed?
- How are drugs reimbursed?
- Is there a payback arrangement?
- Are hospital sales controlled?
- Are OTC prices regulated?
- How are pharmaceutical costs controlled?
- How are generic drugs priced?
- What are wholesale/pharmacy margins?
- Is parallel trade influential?
- What to look out for
- Glossary
- Useful Contacts
Your Basket
Your basket is currently empty.
Search News
News
There are no news items for this country.
View all articles for Latin America »
Related Items




